0001062993-19-002375.txt : 20190522
0001062993-19-002375.hdr.sgml : 20190522
20190522154632
ACCESSION NUMBER: 0001062993-19-002375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190521
FILED AS OF DATE: 20190522
DATE AS OF CHANGE: 20190522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Toby
CENTRAL INDEX KEY: 0001405128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19845620
MAIL ADDRESS:
STREET 1: 4092 BOCAIRE BLVD.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-05-21
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405128
Wegman Toby
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
1
0
Common Stock, $0.001 par value
2019-05-21
4
S
0
5400
64.0531
D
945173
I
See footnote
Common Stock, $0.001 par value
2019-05-21
4
S
0
100
64.665
D
945073
I
See footnote
The selling price of $64.0531 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $63.535 to $64.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
Toby Wegman, by Carl A. Valenstein, attorney-in-fact
2019-05-22